Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 10 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

63%

5 of 8 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (5)
P 2 (1)
P 3 (4)

Trial Status

Completed8
Not Yet Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 8 completed trials

Clinical Trials (10)

Showing 10 of 10 trials
Showing all 10 trials

Research Network

Activity Timeline